electroCore (ECOR) Completes Acquisition of NeuroMetrix
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- S&P Global explores potential separation of Capital IQ business
- Wall Street ends higher on revived AI momentum
- Nebius Group shares jump after France data center funding
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
- Seagate Technology (STX) Tops Q1 EPS by 29c, Offers Guidance
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
May 2, 2025 8:00 AM EDTROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR, electroCore, or the Company) (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today the completion of the merger (the Merger) with NeuroMetrix, Inc. (NeuroMetrix or NURO) (Nasdaq: NURO), positioning itself as a diversified leader in non-invasive health and wellness solutions.
The acquisition of NeuroMetrixs Quell® Fibromyalgia Solution expands electroCores portfolio of non-invasive bioelectronic therapies, strengthens its commercial reach particularly within the VA Hospital System and is expected to meaningfully increase its addressable market for the treatment of chronic pain and wellness conditions.
Dan Goldberger, CEO... More



